Biocept Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BIOC Nasdaq 2834 http://www.biocept.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biocept Inc

The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved - Nov 29th, 2018 6:09 am
What Kind Of Shareholder Appears On The Biocept Inc’s (NASDAQ:BIOC) Shareholder Register? - Nov 20th, 2018 11:19 am
Biocept Reports Third Quarter 2018 Financial Results - Nov 13th, 2018 2:05 pm
Biocept to Release Third Quarter 2018 Financial Results and Host Investor Conference Call on November 13, 2018 - Nov 6th, 2018 6:05 am
Biocept Announces New Executive Hires to its Sales and Marketing Organization - Nov 5th, 2018 6:05 am
Biocept (BIOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Nov 1st, 2018 9:28 am
Biocept to Present at the Dawson James Securities Small Cap Growth Conference on October 30 - Oct 23rd, 2018 6:05 am
Biocept Obtains Japanese Patent for its Target Selector Oncogene Mutation Enrichment and Detection Platform - Oct 18th, 2018 6:05 am
Biocept to Present at The MicroCap Conference in New York on October 2 - Sep 25th, 2018 6:05 am
Biocept Awarded Patent in Hong Kong for its Target Selector Platform Using Antibodies and a Microchannel to Perform Liquid Biopsy - Sep 24th, 2018 6:05 am
Biocept Announces Pricing of $2.5 Million Registered Direct Offering Priced at Market - Sep 21st, 2018 5:00 am
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer - Sep 10th, 2018 6:05 am
Biocept's Target Selector Platform Featured in Two Poster Presentations at the IASLC 19th World Conference on Lung Cancer - Sep 6th, 2018 6:05 am
Highmark Health's VITAL Innovation Program testing benefits of Biocept's liquid biopsy platform for improving outcomes and lowering costs of treatment for patients with non-small cell lung cancer - Aug 23rd, 2018 8:30 am
The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue - Aug 15th, 2018 6:48 am
Biocept Reports Second Quarter 2018 Financial Results - Aug 14th, 2018 2:05 pm
Biocept to Release Second Quarter 2018 Financial Results and Host Investor Conference Call on August 14, 2018 - Aug 9th, 2018 2:05 pm
Biocept Announces $11.6 Million in Expected Gross Proceeds from Recently Expired Rights Offering - Aug 9th, 2018 6:05 am
Biocept Announces Agreement with Managed Care Plan to Study the Benefits of Implementing Liquid Biopsy to Improve Patient Outcomes and Lower Healthcare Costs - Aug 6th, 2018 6:05 am
Biocept Awarded Patent in Canada for its Target Selector CTC Platform - Aug 2nd, 2018 6:05 am